Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.

Abstract

ISIS 13312 possesses antiviral activity and pharmacokinetic properties that favor its use as a therapeutic agent in treatment of CMV retinitis. The half-life of ISIS 13312 in retina is longer than that of ISIS 2922, potentially allowing for less frequent administration.